📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Gem Aromatics Promoter & CFO Kaksha Vipul Parekh Acquires 60,000 Shares via Market Purchase
Kaksha Vipul Parekh, a Promoter and the Whole-Time Director & CFO of Gem Aromatics, has increased their stake in the company through open market transactions. On March 13, 2026, the promoter purchased a total of 60,000 equity shares across the BSE and NSE platforms. This acquisition, valued at approximately ₹1.05 crore, raised the promoter's individual holding from 8.66% to 8.77%. Insider buying of this nature is generally interpreted as a sign of management's confidence in the company's intrinsic value and future growth.
Key Highlights
Promoter Kaksha Vipul Parekh purchased 60,000 equity shares on March 13, 2026.
The total transaction value was approximately ₹1.05 crore excluding taxes and brokerage.
The promoter's individual shareholding increased from 8.66% (4,523,219 shares) to 8.77% (4,583,219 shares).
The acquisition was conducted through open market purchases on both the BSE and NSE.
💼 Action for Investors
Investors should take note of this insider buying as a positive signal regarding the company's outlook. While the stake increase is relatively small (0.11%), the CFO's personal investment suggests alignment with shareholder interests.
Promoter & CFO Kaksha Vipul Parekh Acquires 60,000 Shares of Gem Aromatics for ₹1.06 Cr
Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, purchased 60,000 equity shares via open market transactions on March 13, 2026. The total acquisition cost was approximately ₹1.06 crore, with 50,000 shares bought on BSE and 10,000 on NSE. This purchase increased the promoter's individual stake from 8.66% to 8.77%. Such insider activity often signals management's belief that the current stock price is attractive or that future prospects are strong.
Key Highlights
Purchase of 60,000 shares by Whole-Time Director & CFO Kaksha Vipul Parekh
Total investment value of approximately ₹1.06 crore through open market purchases
Promoter's individual stake increased from 8.66% to 8.77% following the transaction
Purchases were conducted on both BSE (50,000 shares) and NSE (10,000 shares) on March 13, 2026
💼 Action for Investors
This insider purchase is a positive indicator of management's long-term confidence in the business. Investors may consider this a supportive factor for the stock's valuation, though fundamental analysis of the company's earnings remains necessary.
Gem Aromatics Promoter & CFO Kaksha Vipul Parekh Acquires 60,000 Shares for ₹1.06 Crore
Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, has increased their stake in the company through an open market purchase on March 12, 2026. The transaction involved the acquisition of 60,000 equity shares for a total consideration of approximately ₹1.06 crore. This purchase raises the promoter's individual holding from 5.46% to 5.56%. Such insider buying by a key management person is typically interpreted as a sign of confidence in the company's long-term value.
Key Highlights
Acquisition of 60,000 equity shares via open market on the BSE
Total transaction value amounts to ₹1,05,99,000
Promoter's stake increased from 5.46% to 5.56% following the transaction
Transaction executed by Kaksha Vipul Parekh, who serves as Whole-Time Director and CFO
💼 Action for Investors
Investors should take this as a positive signal of management's confidence in the company's valuation. While insider buying is encouraging, it should be weighed alongside the company's quarterly financial performance.
Gem Aromatics Promoter & CFO Acquires 60,000 Shares Worth ₹1.06 Crore
Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, purchased 60,000 shares through an open market transaction on March 12, 2026. The acquisition, valued at approximately ₹1.06 crore, increased her personal stake from 49.46% to 50.12%. Such insider buying by a key financial officer often indicates strong internal confidence in the company's valuation and future performance. This transaction is significant as it crosses the 50% individual ownership threshold for the promoter.
Key Highlights
Purchase of 60,000 equity shares by CFO Kaksha Vipul Parekh via open market
Total transaction value estimated at ₹1,05,99,000
Individual promoter stake increased from 49.46% to 50.12%
Transaction was executed on the BSE on March 12, 2026
💼 Action for Investors
Investors should view this insider buying by the CFO as a positive signal of management's commitment and confidence in the company's long-term prospects.
Gem Aromatics Promoter & CFO Acquires 50,000 Shares Worth ₹93.12 Lakhs
Kaksha Vipul Parekh, the Promoter and CFO of Gem Aromatics Limited, purchased 50,000 equity shares through an open market transaction on March 11, 2026. The acquisition, valued at approximately ₹93.12 lakhs, raised the promoter's stake from 64.54% to 65.27%. This move reflects strong internal confidence in the company's current valuation and long-term business outlook. Insider buying at this scale is often interpreted by the market as a bullish indicator.
Key Highlights
Acquisition of 50,000 equity shares by Promoter and CFO Kaksha Vipul Parekh.
Total transaction value reported at ₹93,12,500 through an on-market purchase.
Individual promoter holding increased from 64.54% to 65.27% post-transaction.
The transaction was executed on March 11, 2026, and disclosed under SEBI PIT regulations.
💼 Action for Investors
Investors should view this insider purchase as a positive signal regarding the company's intrinsic value. It may be worth monitoring the stock for further accumulation by other members of the promoter group.
Gem Aromatics Promoter Kaksha Vipul Parekh Acquires 50,000 Shares for ₹93.12 Lakhs
Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, has purchased 50,000 equity shares of the company through an open market transaction on March 11, 2026. The total value of the acquisition is approximately ₹93.12 lakhs. This purchase has increased the promoter's individual stake from 8.45% to 8.546%. Such insider buying typically indicates management's confidence in the company's future prospects and intrinsic value.
Key Highlights
Promoter and CFO Kaksha Vipul Parekh purchased 50,000 shares via the open market on NSE
The total transaction value is approximately ₹93.12 lakhs
Individual shareholding of the promoter increased from 8.45% to 8.546%
The acquisition was completed on March 11, 2026, as per SEBI PIT regulations
💼 Action for Investors
Investors should consider this insider buying as a positive signal regarding the company's valuation and outlook. It is advisable to monitor further insider activity and quarterly performance to confirm the growth trajectory.
Promoter Vipul Nathalal Parekh Acquires 0.57% Stake in Gem Aromatics via Open Market
Mr. Vipul Nathalal Parekh, a promoter of Gem Aromatics Limited, has increased his stake by acquiring 3,00,000 equity shares through the open market. This transaction, completed on March 04, 2026, represents a 0.57% increase in his total holding. Consequently, his individual stake in the company has risen from 17.64% to 18.21%. Promoter buying from the open market is typically interpreted as a strong signal of confidence in the company's valuation and long-term growth prospects.
Key Highlights
Acquisition of 3,00,000 equity shares (0.57% stake) by promoter Vipul Nathalal Parekh.
Transaction executed via open market on March 04, 2026.
Promoter's total shareholding increased from 92,16,748 shares (17.64%) to 95,16,748 shares (18.21%).
Total paid-up equity capital of the company remains at 5,22,37,138 shares with a face value of Rs. 2 each.
💼 Action for Investors
This insider purchase suggests the promoter believes the current market price is attractive. Investors should view this as a positive indicator of internal confidence while continuing to monitor the company's quarterly performance.
Gem Aromatics Promoter Vipul Nathalal Parekh Acquires 3 Lakh Shares for ₹6.19 Crores
Vipul Nathalal Parekh, a Promoter and Whole-Time Director of Gem Aromatics Limited, has acquired 3,00,000 equity shares of the company through an open market transaction on March 04, 2026. The total value of the acquisition is approximately ₹6.19 Crores, reflecting a significant personal investment. This purchase has increased his individual stake from 17.64% to 18.21%. Such substantial promoter buying is typically interpreted as a strong signal of confidence in the company's long-term value and future prospects.
Key Highlights
Promoter Vipul Nathalal Parekh purchased 3,00,000 equity shares via the open market on March 04, 2026.
The total transaction value is approximately ₹6.187 crore, excluding taxes and brokerage.
The promoter's individual shareholding increased from 17.64% (92,16,748 shares) to 18.21% (95,16,748 shares).
The acquisition was executed on the National Stock Exchange (NSE).
This disclosure was made under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.
💼 Action for Investors
Investors should view this increase in promoter stake as a positive indicator of management's confidence in the company's intrinsic value. It may be worth monitoring the stock for further insider activity or upcoming growth catalysts.
Gem Aromatics Starts New Production at Dahej & Secures $1M Export Orders
Gem Aromatics has commenced commercial production of cooling agents (GEM Cool 5) and Safranal at its Dahej facility through its subsidiary, Krystal Ingredients. The company also secured new export orders totaling USD 1 million from the USA and Europe, signaling a revival in international demand due to easing tariff headwinds. This expansion is part of a larger growth strategy where the company is adding 9,229 MTPA capacity to its existing 6,946 MTPA. Management expects the manufacturing of Catalyst for MEHQ to be completed by Q4FY26, further diversifying the product portfolio.
Key Highlights
Commenced commercial production of GEM Cool 5 and Safranal at the Dahej greenfield facility
Secured new export orders aggregating to USD 1 million from USA and European markets
Total installed capacity stands at 6,946 MTPA with an additional 9,229 MTPA under expansion
Manufacturing of Catalyst for MEHQ is on track for completion by Q4FY26
Revival in export demand attributed to proposed EU FTA and US tariff reductions
💼 Action for Investors
Investors should monitor the revenue ramp-up from the Dahej facility and the successful commissioning of the remaining 9,229 MTPA capacity. The stock offers growth potential as the company transitions from pilot runs to full-scale commercial operations in high-value specialty chemicals.
Gem Aromatics Bags $1M Export Orders and Starts New Product Production at Dahej Facility
Gem Aromatics has secured new export orders totaling USD 1 million from the USA and Europe, signaling a revival in international demand following tariff reductions and trade agreements. The company has also commenced commercial production of new products, including cooling agents and Citral derivatives, at its Dahej greenfield facility via its subsidiary, Krystal Ingredients. This expansion is part of a larger strategy to utilize an additional 9,229 MTPA capacity currently under pilot run. Furthermore, the company expects to complete the manufacturing setup for MEHQ catalysts by Q4FY26.
Key Highlights
Received new export orders worth USD 1 million from customers in the USA and Europe
Commenced commercial production of GEM Cool 5 (Cooling Agents) and Safranal at Dahej facility
Company is scaling up with 9,229 MTPA additional capacity currently under pilot run
Manufacturing of Catalyst for MEHQ is on track for completion by Q4FY26
Export revival driven by proposed EU FTA and easing of US tariff headwinds
💼 Action for Investors
Investors should track the successful transition of the 9,229 MTPA pilot capacity into full commercial operations as it will significantly boost revenue. The recovery in high-margin export markets is a positive indicator for bottom-line growth in the coming quarters.
Gem Aromatics Schedules Plant Visit for 20+ Institutional Investors at Dahej Facility
Gem Aromatics Limited has announced a plant visit for over 20 institutional investors and analysts on February 24, 2026. The visit will take place at the company's Unit 3 facility in Dahej, Gujarat, from 11:30 AM to 3:30 PM. Notable participants include HDFC Securities, Lucky Investment Managers, and Prabhudas Liladhar. The company intends to use its Q3 & 9MFY26 investor presentation for the interaction, highlighting its operational setup to the investment community.
Key Highlights
Plant visit scheduled for February 24, 2026, at the Dahej, Gujarat manufacturing unit.
Over 20 major institutional investors and fund houses confirmed for the site visit.
Participating firms include HDFC Securities, SageOne Investments, and Nirmal Bang Securities.
Discussions will be based on the existing Q3 and 9MFY26 investor presentation.
💼 Action for Investors
Investors should watch for potential research coverage or updates from the participating institutional firms following the site visit. The significant interest from multiple fund houses suggests a positive outlook on the company's manufacturing capabilities.
Gem Aromatics Q3 FY26: Dahej Facility Commissioned, Targets ₹1,100 Cr Revenue by FY28
Gem Aromatics reported Q3 FY26 consolidated revenue of ₹78.9 crore, with gross margins improving significantly to 23% from 14% in the previous quarter. The company successfully commissioned its Greenfield Dahej facility in December 2025, marking a 3x capacity expansion to 16,000 MTPA. Despite a consolidated net loss of ₹5 crore due to high depreciation from the ₹250 crore capitalized capex, management provided strong guidance. The company aims for ₹1,050-1,100 crore in revenue and 16-18% EBITDA margins by FY28 as it diversifies into high-value phenol and cooling agents.
Key Highlights
Commissioned Greenfield Dahej facility on Dec 11, 2025, increasing total capacity 3x to 16,000 MTPA
Consolidated gross margins improved to 23% in Q3 FY26 from 14% in the previous quarter
Incurred ₹250 crore of the planned ₹270 crore total capex for the Dahej facility expansion
Management targets revenue of ₹1,050-1,100 crore and EBITDA margins of 16-18% by FY28
Reported a consolidated net loss of ₹5 crore for Q3 FY26, primarily due to a ₹8.7 crore non-cash depreciation charge
💼 Action for Investors
Investors should focus on the capacity utilization ramp-up at the Dahej plant and the successful commercialization of phenol derivatives in Q1 FY27. While current profitability is masked by high depreciation, the long-term growth trajectory and diversification away from mint-centric products are positive indicators.
Gem Aromatics Q3FY26: Dahej Plant Commissioned; Targets Rs 1,100 Cr Revenue by FY28
Gem Aromatics reported a consolidated revenue of Rs 78.9 Cr for Q3FY26, a 19% YoY decline attributed to tariff uncertainties and GST-related changes. The company achieved a major milestone by commissioning its greenfield Dahej facility on December 11, 2025, with a total capex of Rs 270 Cr. While consolidated PAT showed a loss of Rs 5 Cr due to a high non-cash depreciation charge of Rs 8.7 Cr post-capitalization, standalone EBITDA margins improved to 9.1%. Management has provided a strong long-term guidance, targeting revenues of Rs 1,050-1,100 Cr and EBITDA margins of 16-18% by FY28.
Key Highlights
Commissioned greenfield Dahej plant with 10,829 MTPA capacity on Dec 11, 2025.
Consolidated revenue declined 19% YoY to Rs 78.9 Cr, while standalone EBITDA margin rose to 9.1%.
Reported consolidated loss of Rs 5 Cr driven by Rs 8.7 Cr in non-cash depreciation from new facility.
Management targets aggressive growth to Rs 1,050 - 1,100 Cr revenue by FY28.
Diversifying into high-value cooling agents and phenol derivatives to reduce dependency on mint products.
💼 Action for Investors
Investors should focus on the capacity utilization and ramp-up of the Dahej facility in Q4FY26 as the primary growth driver. While the current bottom line is impacted by depreciation, the transition toward high-margin specialty chemicals and the FY28 guidance suggest significant long-term potential.
Gem Aromatics Q3 Results: Consolidated PAT Slips to Loss of ₹5 Cr on High Capex Depreciation
Gem Aromatics reported a consolidated net loss of ₹5.0 crore for Q3 FY26, a sharp decline from a ₹7.5 crore profit YoY, primarily due to ₹8.7 crore in depreciation following the capitalization of its new Dahej facility. Consolidated revenue fell 18.5% YoY to ₹78.9 crore, impacted by external headwinds like GST changes and tariff uncertainties that led to customer inventory optimization. Despite the short-term bottom-line pressure, the company successfully commenced commercial production at its ₹270 crore Dahej plant in December 2025. Management has issued a long-term guidance targeting revenue of ₹1,050-1,100 crore by FY28.
Key Highlights
Consolidated Q3 revenue declined 18.5% YoY to ₹78.9 crore, while 9MFY26 PAT plummeted to ₹0.4 crore from ₹25.8 crore YoY.
Reported a consolidated net loss of ₹5.0 crore in Q3 FY26, heavily impacted by ₹8.7 crore in non-cash depreciation charges.
Capitalized ₹250 crore of the total ₹270 crore capex for the Dahej facility, which will increase total capacity to approximately 16,000 MTPA.
Commenced commercial production of cooling agents (WS-23, WS-03) and clove derivatives at the Dahej plant on December 11, 2025.
Management targets FY28 revenue of ₹1,050-1,100 crore with EBITDA margins of 16-18% as asset utilization improves.
💼 Action for Investors
The current net loss is primarily an accounting impact from high depreciation of a major new facility; investors should monitor the ramp-up in capacity utilization at Dahej. The long-term investment case depends on the company's successful transition into high-value specialty chemicals and meeting its ambitious FY28 revenue targets.
Gem Aromatics Q3 Standalone PAT Drops 72% YoY to ₹41.28 Million; Revenue Declines
Gem Aromatics reported a weak set of numbers for the quarter ended December 31, 2025, with standalone revenue from operations falling to ₹839.01 million from ₹891.21 million YoY. Net profit saw a sharp decline of 72% YoY, dropping from ₹148.41 million to ₹41.28 million. In a notable move, the Executive Directors have waived their remuneration for FY 2025-26, citing a challenging business environment and poor financial performance. The company has fully utilized its IPO proceeds of ₹1,628.63 million, primarily for debt repayment.
Key Highlights
Standalone Revenue from operations decreased to ₹839.01 million in Q3 FY26 compared to ₹891.21 million in Q3 FY25.
Standalone Net Profit (PAT) plummeted 72% YoY to ₹41.28 million from ₹148.41 million.
Earnings Per Share (EPS) fell significantly to ₹0.79 from ₹3.10 in the same quarter last year.
Executive Directors waived their entire remuneration for FY 2025-26 due to the current business environment.
The company fully utilized ₹1,400 million from IPO proceeds for debt repayment of the company and its subsidiary, Krystal Ingredients.
💼 Action for Investors
Investors should exercise caution as the sharp decline in both revenue and profitability indicates significant operational headwinds. While the management's salary waiver shows alignment with shareholders, the underlying business performance remains under pressure.